Table 2.
Baseline demographic and clinical data of patients with severe or non-severe GERD.
|
Non-severe GERD (n = 234) |
Severe GERD (n = 102) |
p | |
|---|---|---|---|
| Age, years | 45.2 (±13.8) | 46.2 (±13.3) | 0.5374 |
| Female, n (%) | 72 (30.7) | 38 (37.2) | 0.2435 |
| Body mass index, kg/m2 | 24.8 (±3.7) | 25.3 (±3.9) | 0.2634 |
| Heartburn, n (%) | 192 (82.1) | 81 (79.4) | 0.5602 |
| Regurgitation, n (%) | 125 (53.4) | 53 (52) | 0.8134 |
| Dysphagia, n (%) | 13 (5.5) | 12 (11.7) | 0.0460 |
| Symptom duration (years) | 8.3 (±6.9) | 9.7 (±5.1) | 0.0665 |
| PPI use, n (%) | 167 (71.3) | 88 (86.2) | 0.0034 |
| PPI therapy (years) | 6.7 (±5.6) | 7.1 (±5.1) | 0.5369 |
| GERD-HRQL score | 19.2 (±7.7) | 21.0 (±7.5) | 0.0479 |
| Atypical symptoms, n (%) | 6 (2.6) | 3 (2.9) | 0.8760 |
Continuous variables are expressed using mean values (±SD).